With innovation as the watchword, a biotech spinoff from the UCSF School of Pharmacy announced a $40 million Series A round of investment last week – hailed by an investor as “one of the largest first rounds of financing in some time.”
Specialized brain training targeted at the regions of a rat’s brain that process sound reversed many aspects of normal, age-related cognitive decline and improved the health of the brain cells, according to a new study from researchers at UCSF.
More funding will be available this year to support UCSF students from socio- or economically disadvantaged backgrounds, as a result of a 300 percent increase in federal funding for Scholarships for Disadvantaged Students (SDS) program for the upcoming school year.
Results of a clinical trial through the UCSF-sponsored Immune Tolerance Network may offer the first new treatment in 40 years for the devastating blood vessel disease known as anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.